Fed. Circ. Junks Merck's Nasonex Patent Suit Against Apotex
The appeals court's ruling came without explanation less than a week after the panel heard oral arguments on the New Jersey federal court's ruling, which also denied Apotex's efforts to invalidate Merck's patent.
Much of the arguments hinged on X-ray powder diffraction analysis of the anhydrous and monohydrous forms of...
To view the full article, register now.